off-label marketing

Neuron Culture

Tag archives for off-label marketing

You can’t make this stuff up. As PharmaGossip (among others, including the Times) reportst, a drug company pays $2.3 billion in fines to settle charges of unprecedented seriousness about practices that directly put patients at risk, and that came out of a four-year federal investigation. And some yahoo right-winger asserts this fine — years in…

Close on the heels of Lilly’s $1.42 billion penalty for off-label marketing comes the news that Pfizer paid out $2.3 billion to settle similar allegations. From FiercePharma News of the Pfizer-Wyeth merger this morning drowned out some not so good news for the company. Just after announcing its $68 billion buyout of Wyeth, Pfizer published…

I stirred some ire last week when I asserted that the Times (for — disclosure dept — whom I sometimes write) and similar mainstream papers offer a public good through their unique combination of a) access to information and 2) clout with the public and government. Several readers took me to task (see the comments…